Key points are not available for this paper at this time.
RSVpreF vaccine administered during pregnancy was effective against medically attended severe RSV-associated lower respiratory tract illness in infants, and no safety concerns were identified. (Funded by Pfizer; MATISSE ClinicalTrials.gov number, NCT04424316.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Beate Kampmann
Shabir A. Madhi
Iona Munjal
New England Journal of Medicine
Utrecht University
University of Helsinki
University of Colorado Denver
Building similarity graph...
Analyzing shared references across papers
Loading...
Kampmann et al. (Wed,) studied this question.
www.synapsesocial.com/papers/69d727ca8a0e2c5879befa97 — DOI: https://doi.org/10.1056/nejmoa2216480
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: